Medtronic Ventures

Medtronic Ventures is the corporate venture arm of Medtronic, the global medical device company, investing in companies that align with Medtronic’s strategic priorities across cardiovascular, diabetes, neuromodulation, surgical, and digital health categories. Stage focus is typically Series B and beyond, with checks in the $5M to $15M range and the capacity to participate alongside larger institutional syndicates. Healthcare exposure is exclusive and tied to Medtronic’s core franchises: physician founders building devices, device-adjacent software, surgical innovation, and digital health with credible alignment to Medtronic’s commercial portfolio are the right profile. Founders building therapeutics, consumer wellness brands, or generic enterprise software without device alignment will not find a strategic fit. Geographic posture is global, with active deal capacity in North America, Europe, and selectively Asia. The realistic entry path is engagement through Medtronic’s external innovation and business development teams or via a Medtronic business unit sponsor; warm introduction from a co-investing device VC or a clinical adviser in the network meaningfully accelerates the process. Founders should arrive with clear regulatory progress, KOL clinical advisors, and an articulated commercial alignment narrative, and engage independent counsel given the strategic complexity of CVC investments. Treat Medtronic Ventures as a strategic later-stage partner that brings commercial pull, regulatory depth, and global distribution insight rather than a generalist financial lead.